Hikma Pharmaceuticals PLC$HIK
GB00B0LCW083 · LSE
4 directors and managers of Hikma Pharmaceuticals PLC have disclosed 7 transactions under MAR Article 19: 2 buys worth €176k and 0 sells worth €0, which reads as net buying. The most recent disclosed transaction was on 2026-09-21. The largest buy was Tobias Hestler (Non-Executive Director) for €145k. See live cluster buys or start a free 14-day trial to get alerts when Hikma Pharmaceuticals PLC insiders trade.
Insiders
4
Net flow
€176k
Bought
€176k
Sold
€0
Buy Hikma Pharmaceuticals PLC
Pick a broker. We handle the signal, they handle execution.
Affiliate links — we may earn a referral fee if you sign up.
All disclosed transactions
| Date | Type | Insider | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-21 3w ago | BUY | Susan Ringdal PDMR | 1,684 | €15.97 | €31k |
| 2026-08-24 1mo ago | UNKNOWN | PDMR at Hikma Pharmaceuticals Plc PDMR | — | — | — |
| 2026-08-21 1mo ago | UNKNOWN | Said Darwazah Chief Executive Officer | 2,000,000 | — | — |
| 2026-08-11 2mo ago | UNKNOWN | PDMR at Hikma Pharmaceuticals Plc PDMR | — | — | — |
| 2026-08-10 2mo ago | BUY | Tobias Hestler Non-Executive Director | 7,500 | €16.48 | €145k |
| 2026-06-02 4mo ago | UNKNOWN | PDMR at Hikma Pharmaceuticals Plc PDMR | — | — | — |
| 2026-06-01 4mo ago | UNKNOWN | Said Darwazah Chief Executive Officer | — | — | — |